Home › Funds › GW&K Investment Management, LLC › JAZZ
GW&K Investment Management, LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
GW&K Investment Management, LLC reported holding 341,673 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$79.1M, representing 0.67% of its reported portfolio and ranking #34 among its reported holdings. GW&K Investment Management, LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GW&K Investment Management, LLC's JAZZ position evolved
GW&K Investment Management, LLC first disclosed a stake in JAZZ in Q3 2023 at 386,845 shares (US$50.1M). The position peaked in Q2 2026 at 350,667 shares, worth US$84.5M. Across 13 filings, GW&K Investment Management, LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 341,673 shares valued at US$79.1M — a reduction of -8,994 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2024 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 386.85K | $50.07M | New |
| Q4 2023 | 366.87K | $45.12M | Reduce |
| Q1 2024 | 363.75K | $43.80M | Reduce |
| Q2 2024 | 369.35K | $39.42M | Add |
| Q3 2024 | 366.41K | $40.82M | Reduce |
| Q4 2024 | 464.00K | $57.14M | Add |
| Q1 2025 | 470.55K | $58.42M | Add |
| Q2 2025 | 472.56K | $50.15M | Hold |
| Q3 2025 | 454.71K | $59.93M | Reduce |
| Q4 2025 | 427.64K | $72.70M | Reduce |
| Q1 2026 | 371.10K | $70.16M | Reduce |
| Q2 2026 | 350.67K | $84.50M | Reduce |
| Q3 2026 | 341.67K | $79.11M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 42 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
More on GW&K Investment Management, LLC
FAQ
How long has GW&K Investment Management, LLC held JAZZ?
GW&K Investment Management, LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GW&K Investment Management, LLC's current position in JAZZ?
As of Q3 2026, GW&K Investment Management, LLC holds 341.67K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $79.11M, representing 0.67% of its reported portfolio and ranking #34.
Has GW&K Investment Management, LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC reduced its position in JAZZ. The position peaked in Q2 2026 at 350.67K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.